跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
活動
按專業知識、姓名或所屬機構搜尋
臨床醫學研究所
國立成功大學
醫學院
電話
886-6-2353535 Ext. 3643
電子郵件
em73643@email.ncku.edu.tw
網站
https://icmmed.ncku.edu.tw
Postal address
在地圖上顯示
概覽
指紋
網路
概要
(14)
專案
(207)
研究成果
(1194)
設備
(13)
學生論文
(176)
指紋
查看啟用 臨床醫學研究所 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine & Life Sciences
Neoplasms
80%
interleukin 20
57%
Pancreatic Neoplasms
46%
Survival
41%
Therapeutics
41%
Lung Neoplasms
40%
Peroxisome Proliferator-Activated Receptors
35%
Stomach Neoplasms
33%
Inflammation
32%
Genes
31%
Adenocarcinoma of Lung
31%
Phosphorylation
31%
Adenocarcinoma
30%
Proteins
29%
gemcitabine
29%
Growth
28%
Mutation
28%
Cohort Studies
26%
Pancreaticoduodenectomy
24%
Solitary Nucleus
24%
Population
23%
Non-Small Cell Lung Carcinoma
23%
Cytokines
23%
Alzheimer Disease
22%
Phosphatidylinositol 3-Kinase
22%
Wounds and Injuries
21%
MicroRNAs
21%
Glycogen Synthase Kinase 3
21%
Biomarkers
20%
Schizophrenia
20%
Catenins
20%
Kidney
19%
Cell Line
19%
Stroke
18%
Drug Therapy
18%
Hypertension
18%
Reactive Oxygen Species
18%
Liver
18%
Skin
18%
Incidence
17%
In Vitro Techniques
17%
Obesity
17%
Insulin Resistance
17%
Down-Regulation
17%
Acute Coronary Syndrome
17%
Irinotecan
17%
Fluorouracil
16%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
16%
Macrophages
16%
Insulin
16%
Carcinoma
16%
Stem Cells
16%
Confidence Intervals
16%
Gastropoda
16%
Safety
16%
Leucovorin
15%
Cell Movement
15%
Lung
15%
Gastrointestinal Stromal Tumors
15%
Mortality
14%
Hepatocellular Carcinoma
14%
Osteopontin
14%
quinoline
14%
Mouth Neoplasms
14%
Blood Pressure
14%
Brain
14%
Carcinogenesis
14%
Neurons
13%
Protein-Tyrosine Kinases
13%
Stomach
13%
Phosphatidylinositols
13%
collapsin response mediator protein-1
13%
Infections
13%
ErbB Receptors
13%
phosphatidylinositol 3,4,5-triphosphate
13%
Endothelial Cells
12%
Interleukin-1
12%
Interleukins
12%
Tuberculosis
12%
Chronic Renal Insufficiency
12%
Cardiac Myocytes
12%
Esophageal Squamous Cell Carcinoma
12%
Serum
12%
Ligation
12%
Messenger RNA
12%
Myocardial Infarction
12%
Retrospective Studies
12%
Regeneration
12%
Monoclonal Antibodies
12%